-
Nombre total de droits de vote et d鈥檃ctions composant le capital social au 31 janvier 2025 (Conform茅ment 脿 l鈥檃rticle L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du R猫glement...
-
Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2025 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations...
-
Solida crescita del fatturato e margini in espansione nel 2024 Smart glasses nuovo motore della crescita, Nuance pronto per un esordio promettente 鈥� Fatturato in crescita del 9,2% a cambi costanti1...
-
Solide croissance du chiffre d鈥檃ffaires et augmentation de la marge en 2024 Un nouveau vecteur de croissance : les lunettes connect茅es, d茅buts prometteurs de Nuance Audio Hausse de +9,2聽% du...
-
Sound sales growth and margin expansion in 2024 Smartglasses as a new driver, Nuance off to a promising start Group revenue at constant exchange rates1 +9.2% in Q4 and +6.0% in the FYNorth America...
-
EssilorLuxottica acquisisce Cellview, startup med-tech canadese La sua tecnologia proprietaria ultra-widefield consente di acquisire immagini ad alta risoluzione in modo rapido e semplice, offrendo...
-
EssilorLuxottica acquiert la start-up canadienne med-tech Cellview La technologie propri茅taire ultra-grand champ de Cellview permet d'obtenir rapidement et facilement des images de haute qualit茅 de...
-
EssilorLuxottica acquires the Canadian med-tech start-up Cellview The company鈥檚 ultra-widefield proprietary technology allows for fast and easy high-quality images, providing a comprehensive view of...
-
EssilorLuxottica obtient l'autorisation de la FDA et les certifications europ茅ennes pour ses lunettes Nuance Audio qui seront d茅sormais disponibles aux 脡tats-Unis et en Europe Paris, France (3...
-
EssilorLuxottica receives FDA clearance and EU certifications for Nuance Audio, making it available to consumers in the U.S. and Europe Paris, France (3 February 2025) 鈥� EssilorLuxottica announced...